.svg){kind=small}
The event will provide an opportunity to learn about the important research in Malaria conducted by MMV and Richmond Pharmacology, how this clinical partnership supports the WHO Global Technical Strategy for Malaria and how clinical research in London, a global life sciences hub, can support the development of other tropical disease therapies.
This is a limited capacity event, to express an interest in this event or to learn more details, please contact Jack Wilmott on j.wilmott@richmondpharmacology.com
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
